PM-4008

N/A

Report date: 2026/03/19 17:18:25

Base Information

Drug NamePM-4008

Drug Alias NamePM-4008

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 5 antagonistsCarcinoembryonic antigen related cell adhesion molecule 6 inhibitorsCD3 T-cell engagers

TargetsCarcinoembryonic antigen related cell adhesion molecule 5Carcinoembryonic antigen related cell adhesion molecule 6T cell surface glycoprotein CD3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator Companies +[1] N/A

China Registration ClassN/A

Develop Information

Active Companies +[1] N/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A